PADMANEE SHARMA to Tumor Burden
This is a "connection" page, showing publications PADMANEE SHARMA has written about Tumor Burden.
Connection Strength
0.116
-
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275. Clin Cancer Res. 2020 10 01; 26(19):5120-5128.
Score: 0.116